Imaging diagnostics of the prostate;Bildgebung der prostata

Urologe - Ausgabe A

Volumn 49, Issue 8, 2010, Pages 963-975

  Dinter, D J ^a   Weidner, A M ^a   Wenz, F ^a   Pelzer, A E ^a   Michel, M S ^a   Schoenberg, S O ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Imaging; Magnetic resonance imaging; PET CT; Prostate; Ultrasound

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

CANCER SCREENING; CANCER STAGING; COLOR ULTRASOUND FLOWMETRY; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC TEST; DIFFERENTIAL DIAGNOSIS; DIFFUSION WEIGHTED IMAGING; ELASTOGRAPHY; HUMAN; MINIMALLY INVASIVE PROCEDURE; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PERFUSION WEIGHTED IMAGING; POSITRON EMISSION TOMOGRAPHY; PROSTATE CANCER; PROSTATITIS; REVIEW; SENSITIVITY AND SPECIFICITY; TRANSRECTAL ULTRASONOGRAPHY; ULTRASOUND;

DIAGNOSTIC IMAGING; HUMANS; IMAGE ENHANCEMENT; MALE; PROSTATIC NEOPLASMS;

EID: 77955558098     PISSN: 03402592     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00120-010-2338-0     Document Type: Review

References (31)

1. Sakr WA, Haas GP, Cassin BF et al (1993) The frequency of carcinoma and intraepithelial neoplasia of the prostate in young male patients. J Urol 150 379 1:STN:280:DyaK3szhs1eluw%3D%3D 8326560
2. Marks LS, Fradet Y, Deras IL et al (2007) PCA3 molecular urine assay for prostate cancer in men undergoing repeat biopsy. Urology 69 532 10.1016/j.urology.2006.12.014 17382159 (Pubitemid 46428401)
3. Carter HB, Hamper UM, Sheth S et al (1989) Evaluation of transrectal ultrasound in the early detection of prostate cancer. J Urol 142 1008 1:STN:280:DyaK3c%2Fht1eksg%3D%3D 2677409
4. Rifkin MD, Sudakoff GS, Alexander AA (1993) Prostate: techniques, results, and potential applications of color Doppler US scanning. Radiology 186 509 1:STN:280:DyaK3s7jsVSltg%3D%3D 7678467
5. Pelzer A, Bektic J, Berger AP et al (2005) Prostate cancer detection in men with prostate specific antigen 4 to 10 ng/ml using a combined approach of contrast enhanced color Doppler targeted and systematic biopsy. J Urol 173 1926 10.1097/01.ju.0000158444.56199.03 15879783 (Pubitemid 40675213)
6. Pallwein L, Mitterberger M, Struve P et al (2007) Real-time elastography for detecting prostate cancer: preliminary experience. BJU Int 100 42 10.1111/j.1464-410X.2007.06851.x 17552952 (Pubitemid 46878542)
7. Salomon G, Kollerman J, Thederan I et al (2008) Evaluation of prostate cancer detection with ultrasound real-time elastography: a comparison with step section pathological analysis after radical prostatectomy. Eur Urol 54 1354 10.1016/j.eururo.2008.02.035 18374470
8. Hricak H, Choyke PL, Eberhardt SC et al (2007) Imaging prostate cancer: a multidisciplinary perspective. Radiology 243 28 10.1148/radiol.2431030580 17392247 (Pubitemid 46579693)
9. Kim CK, Park BK (2008) Update of prostate magnetic resonance imaging at 3 T. J Comput Assist Tomogr 32 163 10.1097/RCT.0b013e3180683b99 18379296 (Pubitemid 351489432)
10. Qayyum A, Coakley FV, Lu Y et al (2004) Organ-confined prostate cancer: effect of prior transrectal biopsy on endorectal MRI and MR spectroscopic imaging. AJR Am J Roentgenol 183 1079 15385308
11. Shimizu T, Nishie A, Ro T et al (2009) Prostate cancer detection: the value of performing an MRI before a biopsy. Acta Radiol 50 1080 10.3109/02841850903216718 1:STN:280:DC%2BD1Mjit1ChsQ%3D%3D 19863420
12. Beyersdorff D, Taupitz M, Winkelmann B et al (2002) Patients with a history of elevated prostate-specific antigen levels and negative transrectal US-guided quadrant or sextant biopsy results: value of MR imaging. Radiology 224 701 10.1148/radiol.2243011553 12202702
13. Vilanova JC, Comet J, Barcelo-Vidal C et al (2009) Peripheral zone prostate cancer in patients with elevated PSA levels and low free-to-total PSA ratio: detection with MR imaging and MR spectroscopy. Radiology 253 135 10.1148/radiol.2531082049 19703854
14. Futterer JJ, Barentsz J, Heijmijnk ST (2009) Imaging modalities for prostate cancer. Expert Rev Anticancer Ther 9 923 10.1586/era.09.63 19589032
15. Cohen RJ, Shannon BA, Phillips M et al (2008) Central zone carcinoma of the prostate gland: a distinct tumor type with poor prognostic features. J Urol 179 1762 10.1016/j.juro.2008.01.017 18343454
16. Riches SF, Payne GS, Morgan VA et al (2009) MRI in the detection of prostate cancer: combined apparent diffusion coefficient, metabolite ratio, and vascular parameters. AJR Am J Roentgenol 193 1583 10.2214/AJR.09.2540 19933651
17. Kim CK, Park BK, Kim B (2010) High-b-value diffusion-weighted imaging at 3 T to detect prostate cancer: comparisons between b values of 1,000 and 2,000 s/mm2. AJR Am J Roentgenol 194 W33 10.2214/AJR.09.3004 20028888
18. Heijmink SW, Futterer JJ, Hambrock T et al (2007) Prostate cancer: body-array versus endorectal coil MR imaging at 3 T-comparison of image quality, localization, and staging performance. Radiology 244 184 10.1148/radiol. 2441060425 17495178 (Pubitemid 46981973)
19. Shukla-Dave A, Hricak H, Moskowitz C et al (2007) Detection of prostate cancer with MR spectroscopic imaging: an expanded paradigm incorporating polyamines. Radiology 245 499 10.1148/radiol.2452062201 17890357 (Pubitemid 47612532)
20. Zakian KL, Sircar K, Hricak H et al (2005) Correlation of proton MR spectroscopic imaging with gleason score based on step-section pathologic analysis after radical prostatectomy. Radiology 234 804 10.1148/radiol. 2343040363 15734935 (Pubitemid 40250824)
21. Futterer JJ, Scheenen TW, Heijmink SW et al (2007) Standardized threshold approach using three-dimensional proton magnetic resonance spectroscopic imaging in prostate cancer localization of the entire prostate. Invest Radiol 42 116 10.1097/01.rli.0000251541.03822.bb 17220729 (Pubitemid 46104892)
22. Franiel T, Ludemann L, Rudolph B et al (2008) Evaluation of normal prostate tissue, chronic prostatitis, and prostate cancer by quantitative perfusion analysis using a dynamic contrast-enhanced inversion-prepared dual-contrast gradient echo sequence. Invest Radiol 43 481 10.1097/RLI. 0b013e31816b2f63 18580330
23. Barentsz JO, Futterer JJ, Takahashi S (2007) Use of ultrasmall superparamagnetic iron oxide in lymph node MR imaging in prostate cancer patients. Eur J Radiol 63 369 10.1016/j.ejrad.2007.06.025 17689215 (Pubitemid 47321043)
24. Jong IJ de, Pruim J, Elsinga PH et al (2002) Visualization of prostate cancer with 11C-choline positron emission tomography. Eur Urol 42 18 10.1016/S0302-2838(02)00129-X 12121724 (Pubitemid 35345101)
25. Jong IJ de, Pruim J, Elsinga PH et al (2003) Preoperative staging of pelvic lymph nodes in prostate cancer by 11C-choline PET. J Nucl Med 44 331 12620996
26. Farsad M, Schiavina R, Castellucci P et al (2005) Detection and localization of prostate cancer: correlation of (11)C-choline PET/CT with histopathologic step-section analysis. J Nucl Med 46 1642 1:CAS:528: DC%2BD28XitVGlt74%3D 16204714
27. Martorana G, Schiavina R, Corti B et al (2006) 11C-choline positron emission tomography/computerized tomography for tumor localization of primary prostate cancer in comparison with 12-core biopsy. J Urol 176 954 10.1016/j.juro.2006.04.015 1:STN:280:DC%2BD28vmsl2nsA%3D%3D 16890665 (Pubitemid 44142558)
28. Reske SN, Blumstein NM, Neumaier B et al (2006) Imaging prostate cancer with 11C-choline PET/CT. J Nucl Med 47 1249 1:CAS:528:DC%2BD28XptVWqu7w%3D 16883001
29. Heinisch M, Dirisamer A, Loidl W et al (2006) Positron emission tomography/computed tomography with F-18-fluorocholine for restaging of prostate cancer patients: meaningful at PSA <5 ng/ml? Mol Imaging Biol 8 43 10.1007/s11307-005-0023-2 16315004 (Pubitemid 44193401)
30. Giovacchini G, Picchio M, Coradeschi E et al (2010) Predictive factors of [(11)C]choline PET/CT in patients with biochemical failure after radical prostatectomy. Eur J Nucl Med Mol Imaging 37 301 10.1007/s00259-009-1253-3 19756592
31. Rinnab L, Simon J, Hautmann RE et al (2009) [(11)C]choline PET/CT in prostate cancer patients with biochemical recurrence after radical prostatectomy. World J Urol 27 619 10.1007/s00345-009-0371-7 1:CAS:528:DC%2BD1MXhtFOrtLnF 19234708